Business ❯ Finance ❯ Investment Strategies ❯ Market Analysis

Stock Performance

Novartis to Buy Avidity Biosciences for $12 Billion, Adding Muscle-Targeted RNA Drugs

The purchase bets on Avidity’s muscle-targeted RNA platform as Novartis pushes deeper into rare neuromuscular disease.

Strategy Lifts Bitcoin Treasury to 640,250 BTC With $27.2 Million Purchase

Ark Invest Adds Alibaba, Baidu on Back-to-Back Days, Cuts Brera, Trims Shopify

Strategy’s MSTR Slips Below $300 as Bitcoin Drops, Premium Hits Year Low